Bionano Genomics Statistics
Total Valuation
BNGO has a market cap or net worth of $17.10 million. The enterprise value is $12.71 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BNGO has 10.18 million shares outstanding. The number of shares has increased by 220.18% in one year.
| Current Share Class | 10.18M |
| Shares Outstanding | 10.18M |
| Shares Change (YoY) | +220.18% |
| Shares Change (QoQ) | +55.13% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 6.70% |
| Float | 9.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.19 |
| Forward PS | 0.50 |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.12 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -46.25 |
Financial Efficiency
Return on equity (ROE) is -78.22% and return on invested capital (ROIC) is -23.24%.
| Return on Equity (ROE) | -78.22% |
| Return on Assets (ROA) | -19.32% |
| Return on Invested Capital (ROIC) | -23.24% |
| Return on Capital Employed (ROCE) | -45.85% |
| Revenue Per Employee | $287,200 |
| Profits Per Employee | -$385,870 |
| Employee Count | 100 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 1.45 |
Taxes
In the past 12 months, BNGO has paid $33,000 in taxes.
| Income Tax | 33,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.28% in the last 52 weeks. The beta is 2.34, so BNGO's price volatility has been higher than the market average.
| Beta (5Y) | 2.34 |
| 52-Week Price Change | -88.28% |
| 50-Day Moving Average | 1.78 |
| 200-Day Moving Average | 3.10 |
| Relative Strength Index (RSI) | 46.64 |
| Average Volume (20 Days) | 297,450 |
Short Selling Information
The latest short interest is 1.15 million, so 11.27% of the outstanding shares have been sold short.
| Short Interest | 1.15M |
| Short Previous Month | 903,990 |
| Short % of Shares Out | 11.27% |
| Short % of Float | 12.55% |
| Short Ratio (days to cover) | 3.20 |
Income Statement
In the last 12 months, BNGO had revenue of $28.72 million and -$38.59 million in losses. Loss per share was -$11.75.
| Revenue | 28.72M |
| Gross Profit | 13.20M |
| Operating Income | -25.72M |
| Pretax Income | -38.55M |
| Net Income | -38.59M |
| EBITDA | -16.13M |
| EBIT | -25.72M |
| Loss Per Share | -$11.75 |
Full Income StatementBalance Sheet
The company has $21.58 million in cash and $17.20 million in debt, giving a net cash position of $4.39 million or $0.43 per share.
| Cash & Cash Equivalents | 21.58M |
| Total Debt | 17.20M |
| Net Cash | 4.39M |
| Net Cash Per Share | $0.43 |
| Equity (Book Value) | 49.80M |
| Book Value Per Share | 5.12 |
| Working Capital | 25.82M |
Full Balance SheetCash Flow
| Operating Cash Flow | -18.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | -18.67M |
| FCF Per Share | -$1.84 |
Full Cash Flow StatementMargins
Gross margin is 45.97%, with operating and profit margins of -89.54% and -134.36%.
| Gross Margin | 45.97% |
| Operating Margin | -89.54% |
| Pretax Margin | -134.24% |
| Profit Margin | -134.36% |
| EBITDA Margin | -56.16% |
| EBIT Margin | -89.54% |
| FCF Margin | n/a |
Dividends & Yields
BNGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -220.18% |
| Shareholder Yield | -220.18% |
| Earnings Yield | -225.71% |
| FCF Yield | -109.23% |
Analyst Forecast
The average price target for BNGO is $6.33, which is 276.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.33 |
| Price Target Difference | 276.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 21.62% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 1:60.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:60 |
Scores
BNGO has an Altman Z-Score of -12.57 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.57 |
| Piotroski F-Score | 4 |
